<DOC>
	<DOCNO>NCT00349726</DOCNO>
	<brief_summary>This pilot study randomize , placebo-controlled , clinical trial measure change blood urine level inositol premature infant high risk retinopathy prematurity ( ROP ) follow single intravenous dose inositol . Based previous study , premise maintain inositol concentration similar occur naturally utero reduce rate ROP bronchopulmonary dysplasia premature infant . The objective evaluate single-dose pharmacokinetics safety different amount intravenous myo-inositol ( provide Ross Products Division , Abbott Laboratories ) low birth weight neonate , preparation future Phase III multi-center randomize controlled trial . This study enrol 74 infant high risk retinopathy 9 NICHD Neonatal Research Network sit , randomly assign receive either 60mg/kg 5 % inositol , 120 mg/kg 5 % inositol , 60 mg/kg 5 % glucose ( placebo ) , 120 mg/kg 5 % glucose .</brief_summary>
	<brief_title>Single-Dose Intravenous Inositol Pharmacokinetics Preterm Infants</brief_title>
	<detailed_description>Retinopathy prematurity ( ROP ) abnormal growth blood vessel eye occur primarily premature infant . Eye development occur normally womb ; infant bear prematurely , however , blood vessel must finish develop outside protective environment uterus . Retinopathy prematurity ( also know retrolental fibroplasia ) lead cause blindness vision impairment ( myopia , strabismus , amblyopia ) child , develop develop country . Inositol naturally-occurring sugar alcohol produce placenta present high level fetal blood throughout pregnancy human animal . Serum level fall rapidly birth , although fall moderate infant receive breast milk . Two randomized trial show intravenous inositol supplementation first week significantly reduce death , bronchopulmonary dysplasia ( BPD ) , retinopathy . One study oral supplement less convincing , also support reduction retinopathy . This pilot study evaluate half-life pharmacokinetics single-dose myo-inositol ( provide Ross Products Division , Abbott Laboratories ) low birth weight infant , look change blood urine inositol level . The premise maintain inositol concentration similar occur naturally utero reduce rate retinopathy bronchopulmonary dysplasia premature infant . Results study used select dose subsequent multi-dose pilot study , plan large multi-center trial . In study , nine NICHD Neonatal Research Network sit enrol 74 infant less 30 week gestation randomly assign receive either 60mg/kg 5 % inositol , 120 mg/kg 5 % inositol , 60 mg/kg 5 % glucose ( placebo ) , 120 mg/kg 5 % glucose . Concentrations inositol measure blood urine determine population pharmacokinetic parameter infant . Stratification : Enrolled infant stratify age 37 infant 23 0/7 26 6/7 week one group 37 infant 27 0/7 29 6/7 week second group .</detailed_description>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Retinopathy Prematurity</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>23 0/7 26 6/7 week gestational age ( 36 infant ) 27 0/7 29 6/7 week gestational age ( 36 infant ) 6001500 gram birth weight No enteral feeding since birth enrollment 36 day ( 25132 hour ) postnatal age Note : Because high mortality expect population ( 1520 % ) , study design ( originally 72 infant ) require recruitment replacement subject infant fail complete four blood sample first week study . Major congenital anomaly Moribund provide continued support Renal failure suspect ( creatinine &gt; 2.5 oliguria ) Exchange transfusion receive expected receive</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Days</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>NICHD Neonatal Research Network</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Inositol</keyword>
	<keyword>Very Low Birth Weight ( VLBW )</keyword>
	<keyword>Extremely Low Birth Weight ( ELBW )</keyword>
	<keyword>Prematurity</keyword>
</DOC>